TransMedics Group, Inc. (TMDX): Operating Cash Flow

Annual figures by period end, from SEC filings.

$192.84M
Year ended 2025-12-31
$145.93M
Trailing 12 months to 2026-06-30
2018-12-29: -$25.98M2019-12-28: -$32.29M2020-12-31: -$30.27M2021-12-31: -$28.86M2022-12-31: -$45.82M2023-12-31: -$13.03M2024-12-31: $48.80M2025-12-31: $192.84M$192.84M
2018-12-29 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$192.84M+295.1%2026-02-24, From 2025-01-01
2024-12-31$48.80Mn/m2026-02-24, From 2024-01-01
2023-12-31-$13.03Mn/m2026-02-24, From 2023-01-01
2022-12-31-$45.82Mn/m2025-02-27, From 2022-01-01
2021-12-31-$28.86Mn/m2024-02-27, From 2021-01-01
2020-12-31-$30.27Mn/m2023-02-27, From 2019-12-29
2019-12-28-$32.29Mn/m2021-03-11, From 2018-12-30
2018-12-29-$25.98Mn/a2020-03-17, From 2017-12-31

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
TransMedics Group, Inc. (TMDX)2025-12-31$192.84M+295.1%
InMode Ltd. (INMD)2025-12-31$85.26M-35.7%
Conmed Corp (CNMD)2025-12-31$170.69M+2.2%
LivaNova PLC (LIVN)2025-12-31$254.34M+39.0%
Axogen, Inc. (AXGN)2025-12-31$812.0K-82.1%
Integer Holdings Corp (ITGR)2025-12-31$196.15M-4.4%
Outset Medical, Inc. (OM)2025-12-31-$46.33Mn/m
Biolife Solutions Inc (BLFS)2025-12-31$20.11M+138.6%
Vaso Corp (VASO)2025-12-31$9.27M+182.6%

Compare TMDX, INMD, CNMD, LIVN side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗